RM53 RM53 (Sunitinib Malate 12.5 mg)
Pill with imprint RM53 RM53 is Brown, Capsule-shape and has been identified as Sunitinib Malate 12.5 mg. It is supplied by Sun Pharmaceutical Industries Inc.
Sunitinib is used in the treatment of gastrointestinal stromal tumor; renal cell carcinoma; pancreatic cancer and belongs to the drug classes multikinase inhibitors, VEGF/VEGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Sunitinib 12.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for RM53 RM53
Sunitinib Malate
- Imprint
- RM53 RM53
- Strength
- 12.5 mg
- Color
- Brown
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors, VEGF/VEGFR inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sun Pharmaceutical Industries Inc.
- National Drug Code (NDC)
- 63304-0091
- Inactive Ingredients
-
croscarmellose sodium,
magnesium stearate,
mannitol,
povidone k30,
ferric oxide red,
titanium dioxide,
potassium hydroxide,
shellac,
gelatin
Note: Inactive ingredients may vary.
More about sunitinib
- Check interactions
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
